Privacy Policy

ACADIA Pharmaceuticals Inc. (“ACADIA”) knows that you care how information about you is used and shared, and we appreciate your trust that we will do so carefully and sensibly. This notice describes our privacy policy. By visiting this website, you are accepting the practices described in this Privacy Policy. Please carefully read the Terms of Use and this Privacy Policy completely before using this website.

Because we will continue to implement new technologies and improve the services and features we provide on our website, this statement is subject to change without prior notice. We reserve the right to update the Privacy Policy at any time. Any changes or updates will be effective immediately upon posting to the website. For that reason, we encourage you to review this statement periodically. By using our website, you agree to our Terms of Use and our Privacy Policy in effect at that time without modification. If you do not agree to these terms, please exit from the website immediately.

Information Sharing

ACADIA is the sole owner of any information collected on this website. We will not sell, share, or rent this information to others in ways different from what is disclosed in this statement. ACADIA may collect information from our users at several different points on our website.

We intend to give you as much control as reasonably possible over your personal information. In general, you can visit this website without telling us who you are or revealing any information about yourself. There are times when we may need information from you in order to service your needs. If you choose to give us personal information we may use that information to correspond with you or provide you with requested materials. If you tell us that you do not wish to have this information used as a basis for further contact, we will respect your wishes. We may analyze this data for trends and statistics, but we will not share the information with third parties unless necessary to provide services to you or as may be required by law.

Logging Site Traffic

ACADIA maintains log files of the site traffic on its websites. We do not link any information gathered in these log files to personal information. Log files are used to manage traffic loads, identify the content most commonly accessed, and information technology requirements for providing reliable service. Information collected includes IP addresses and browser types.

Cookies

“Cookies” can be used to provide you with tailored information from a website. This website may use “cookies” so that we can better serve you when you return to our site. A cookie is a text file that is placed on your hard disk by a Web server. Cookies are uniquely assigned to you, and can only be read by a Web server in the domain that issued the cookie to you. Cookies cannot be used to run programs or deliver viruses to your computer.

Most Web browsers automatically accept cookies, but you can usually modify your browser setting to decline cookies. If you choose to decline cookies, you may not be able to fully utilize all features of this website. You have the ability to delete cookie files from your hard drive at any time.

Back to top
+ Expand - Close

Important Safety Information and Indication for NUPLAZID (pimavanserin) 17-mg Tablets

Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking antipsychotic drugs are at an increased risk of death. NUPLAZID is not approved for the treatment of patients with dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis. Continues below

NUPLAZID may cause serious side effects including:

QT Interval Prolongation: NUPLAZID may increase the risk of changes to your heart rhythm. This risk may increase if NUPLAZID is taken with certain other medications known to change heart rhythm. Tell your healthcare provider about all the medicines you take or have recently taken.

It is important to talk to your healthcare provider about the possible side effect of changes to your heart rhythm. Call your healthcare provider right away if you feel a change in your heartbeat.

Do not take NUPLAZID if you have certain kinds of heart conditions such as:

  • An irregular heartbeat
  • A slow heart rate

Before taking NUPLAZID, tell your healthcare provider if you have:

  • Reduced kidney function. NUPLAZID is not recommended if you have severe kidney problems.
  • Reduced liver function. NUPLAZID is not recommended if you have liver problems.

Other medicines may affect how NUPLAZID works. Some medicines should not be taken with NUPLAZID. Your healthcare provider can tell you if it is safe to take NUPLAZID with your other medicines. Do not start or stop any medicines while taking NUPLAZID without talking to your healthcare provider first.

The most common side effects of NUPLAZID include swelling in the legs or arms, nausea, confusion, hallucination, constipation, and changes to normal walking. These are not all the possible side effects of NUPLAZID. For more information, ask your healthcare provider about this medicine.

Tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known if NUPLAZID may harm your unborn baby.

It is not known if NUPLAZID is safe and effective in people under 18 years of age.

Dosage and Administration

The recommended dose of NUPLAZID is 34 mg per day, taken as two 17‑mg tablets, once per day.

Indication

NUPLAZID is a prescription medicine used to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088. You can also call ACADIA Pharmaceuticals Inc. at 1‑844‑4ACADIA (1‑844‑422‑2342).

Please see full Prescribing Information including Boxed WARNING.

This website is intended for use by US residents.

+ Expand - Close

Important Safety Information and Indication for NUPLAZID (pimavanserin) 17-mg Tablets

Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking antipsychotic drugs are at an increased risk of death. NUPLAZID is not approved for the treatment of patients with dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis. Continues below

NUPLAZID may cause serious side effects including:

QT Interval Prolongation: NUPLAZID may increase the risk of changes to your heart rhythm. This risk may increase if NUPLAZID is taken with certain other medications known to change heart rhythm. Tell your healthcare provider about all the medicines you take or have recently taken.

It is important to talk to your healthcare provider about the possible side effect of changes to your heart rhythm. Call your healthcare provider right away if you feel a change in your heartbeat.

Do not take NUPLAZID if you have certain kinds of heart conditions such as:

  • An irregular heartbeat
  • A slow heart rate

Before taking NUPLAZID, tell your healthcare provider if you have:

  • Reduced kidney function. NUPLAZID is not recommended if you have severe kidney problems.
  • Reduced liver function. NUPLAZID is not recommended if you have liver problems.

Other medicines may affect how NUPLAZID works. Some medicines should not be taken with NUPLAZID. Your healthcare provider can tell you if it is safe to take NUPLAZID with your other medicines. Do not start or stop any medicines while taking NUPLAZID without talking to your healthcare provider first.

The most common side effects of NUPLAZID include swelling in the legs or arms, nausea, confusion, hallucination, constipation, and changes to normal walking. These are not all the possible side effects of NUPLAZID. For more information, ask your healthcare provider about this medicine.

Tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known if NUPLAZID may harm your unborn baby.

It is not known if NUPLAZID is safe and effective in people under 18 years of age.

Dosage and Administration

The recommended dose of NUPLAZID is 34 mg per day, taken as two 17‑mg tablets, once per day.

Indication

NUPLAZID is a prescription medicine used to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088. You can also call ACADIA Pharmaceuticals Inc. at 1‑844‑4ACADIA (1‑844‑422‑2342).

Please see full Prescribing Information including Boxed WARNING.

This website is intended for use by US residents.